Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Gabriela Vazquez Rodriguez"'
Autor:
Gabriel Lindahl, Sebastian Fjellander, Karthik Selvaraj, Malin Vildeval, Zaheer Ali, Rusul Almter, Anna Erkstam, Gabriela Vazquez Rodriguez, Annelie Abrahamsson, Åsa Rydmark Kersley, Anna Fahlgren, Preben Kjølhede, Stig Linder, Charlotta Dabrosin, Lasse Jensen
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-11 (2024)
Abstract Epithelial ovarian cancer (EOC) is the gynaecological malignancy with highest mortality. Although adjuvant treatment with carboplatin and paclitaxel leads to an objective response in ~80% of these patients, a majority will relapse within two
Externí odkaz:
https://doaj.org/article/eb920a96370d421da6f27a581866a236
Autor:
Zaheer Ali, Malin Vildevall, Gabriela Vazquez Rodriguez, Decky Tandiono, Ioannis Vamvakaris, Georgios Evangelou, Georgios Lolas, Konstantinos N. Syrigos, Alberto Villanueva, Michael Wick, Shenga Omar, Anna Erkstam, Julia Schueler, Anna Fahlgren, Lasse D. Jensen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-18 (2022)
Abstract Background Accurate predictions of tumor dissemination risks and medical treatment outcomes are critical to personalize therapy. Patient-derived xenograft (PDX) models in mice have demonstrated high accuracy in predicting therapeutic outcome
Externí odkaz:
https://doaj.org/article/4236a5e70594485dbdefb6a7c7592f35
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
The majority of estrogen receptor positive (ER+) breast cancer (BC) maintain the ER at metastatic sites. Despite anti-estrogen therapy, almost 30% of ER+ BC patients relapse. Thus, new therapeutic targets for ER+ BC are needed. Amino acids (AAs) may
Externí odkaz:
https://doaj.org/article/140036221a02471a8e8d862921673e13
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Fat is a major tissue component in human breast cancer (BC). Whether breast adipocytes (BAd) affect early stages of BC metastasis is yet unknown. BC progression is dependent on angiogenesis and inflammation, and interleukin-8 (IL-8) and vascular endo
Externí odkaz:
https://doaj.org/article/0da0a528b6204fe1af6f63b995c2e248
Autor:
Gabriela Vazquez-Rodriguez, Edgar R. Juvera Avalos, Carmen Gonzalez, Ana P. Barba de la Rosa, Antonio De Leon-Rodriguez
Publikováno v:
Process Biochemistry. 119:1-12
Video showing how neutrophils closely interact with breast cancer cells in the metastatic niche and participate in breast cancer cells transendothelial migration.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05594e153a51eb2ec2e10b0b901fb33b
https://doi.org/10.1158/2326-6066.22537649.v1
https://doi.org/10.1158/2326-6066.22537649.v1
Estradiol (E2) plays a key role in breast cancer progression. Most breast cancer recurrences express the estrogen receptor (ER), but nearly 50% of patients are resistant to antiestrogen therapy. Novel therapeutic targets of ER-positive breast cancers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a02ff46e4c082fada3c7377941f53428
https://doi.org/10.1158/2326-6066.c.6548513.v1
https://doi.org/10.1158/2326-6066.c.6548513.v1
Supplementary materials and figure legends. Supplementary Table 1: Characteristics of breast cancers subjected to microdialysis.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a033227bb9c77854618d7e3e2b0f72b
https://doi.org/10.1158/2326-6066.22537658
https://doi.org/10.1158/2326-6066.22537658
Video showing how eutrophils aid the intravasation and invasion of breast cancer cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00740b022d0f7d5b0f0872159c7becb2
https://doi.org/10.1158/2326-6066.22537655
https://doi.org/10.1158/2326-6066.22537655
Video showing how breast cancer cells invasion and movement is impaired due to blocking LFA-1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed83458f45ded08de7acb813a42fd31
https://doi.org/10.1158/2326-6066.22537646
https://doi.org/10.1158/2326-6066.22537646